Although 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) has been shown to damage brain serotonin (5-HT) neurons in animals and possibly humans, little is known about the long-term consequences of MDMA-induced 5-HT neurotoxic lesions on functions in which 5-HT is involved, such as cognitive function. Because 5-HT transporters play a key element in the regulation of synaptic 5-HT transmission it may be important to control for the potential covariance effect of a polymorphism in the 5-HT transporter promoter gene region (5-HTTLPR) when studying the effects of MDMA as well as cognitive functioning.
The aim of the study was to investigate the effects of moderate and heavy MDMA use on cognitive function, as well as the effects of longterm abstention from MDMA, in subjects genotyped for 5-HTTLPR. A second aim of the study was to determine whether these effects differ for females and males.
Fifteen moderate MDMA users (55 lifetime tablets), 22 heavy MDMA β users (δ 55 lifetime tablets), 16 ex-MDMA β users (last tablet δ 1 year ago) and 13 controls were compared on a battery of neuropsychological tests. DNA from peripheral nuclear blood cells was genotyped for 5-HTTLPR using standard polymerase chain reaction methods.
A signi.cant group effect was observed only on memory function tasks (p 0.04) but not on reaction times (p 0.61) or attention/ executive functioning (p 0.59). Heavy and ex-MDMA β users performed signi.cantly poorer on memory tasks than controls. In contrast, no evidence of memory impairment was observed in moderate MDMA users. No signi.cant effect of 5-HTTLPR or gender was observed.
While the use of MDMA in quantities that may be considered ëmoderateí is not associated with impaired memory functioning, heavy use of MDMA use may lead to long lasting memory impairments. No effect of 5-HTTLPR or gender on memory function or MDMA use was observed.
Alpherts W , Aldenkamp A (1995) FEPSY The Iron Psychy 5.0A. Instituut voor Epilepsiebestrijding, Heemstede, The Netherlands
2.
Altman H J , Normile H J (1988) What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia . Neurobiol Aging9: 627–638
3.
Benton A L , Hamsher K (1989) Multilingual Aphasia Examination. AJA Associates, Iowa City, IA
4.
Bhattachary S , Powell J H (2001) Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment . Psychol Med31: 647–658
5.
Bolla K I , McCann U D , Ricaurte G A (1998) Memory impairment in abstinent MDMA (‘Ecstasy’) users . Neurology51: 1532–1537
6.
Boot B P , McGregor I S , Hall W (2000) MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks . Lancet355: 1818–1821
7.
Buchert R , Thomasius R , Wilke F , Petersen K , Nebeling B , Obrocki J , Schulze O , Schmidt U , Clausen M (2004) A voxel-based PET investigation of the long-term effects of ‘Ecstasy’ consumption on brain serotonin transporters . Am J Psychiatry161: 1181–1189
8.
Buhot M C (1997) Serotonin receptors in cognitive behaviors . Curr Opin Neurobiol7: 243–254
9.
Collier D A , Stober G , Li T , Heils A , Catalano M , Di Bella D , Arranz M J , Murray R M , Vallada H P , Bengel D , Muller C R , Roberts G W , Smeraldi E , Kirov G , Sham P , Lesch K P (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders . Mol Psychiatry1: 453–460
10.
Commins D L , Vosmer G , Virus R M , Woolverton W L , Schuster C R , Seiden, L S (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain . J Pharmacol Exp Ther241: 338–345
11.
Croft R J , Mackay A J , Mills A T , Gruzelier J G (2001) The relative contributions of ecstacy and cannabis to cognitive impairment . Psychopharmacology153: 373–379
12.
Dafters R I , Hoshi R , Talbot A C (2004) Contribution of cannabis and MDMA (‘ecstasy’) to cognitive changes in long-term polydrug users . Psychopharmacology173: 405–410
13.
Daumann J Jr , Fischermann T , Heekeren K , Thron A , Gouzoulis-Mayfrank E (2004) Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study . Biol Psychiatry56: 349–355
14.
Daumann J , Hensen G , Thimm B , Rezk M , Till B , Gouzoulis-Mayfrank E (2004) Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation . Psychopharmacology173: 398–404
15.
Du L , Faludi G , Palkovits M , Demeter E , Bakish D , Lapierre Y D , Sotonyi P , Hrdina P D (1999) Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims . Biol Psychiatry46: 196–201
16.
von Geusau NA , Stalenhoef P , Huizinga M , Snel J , Ridderinkhof K R (2004) Impaired executive function in male MDMA (‘ecstasy’) users . Psychopharmacology175: 331–341 .
17.
Gouzoulis-Mayfrank E , Thimm B , Rezk M , Hensen G , Daumann J (2003) Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users . Prog Neuropsychopharmacol Biol Psychiatry27: 819–827
18.
Hammes J G W (1978) De Stroop kleur-woord test. Hanleiding, tweede gewijzigde druk. The Stroop color-word test. Manual, 2nd revised edition. Swets & Zeitlinger, Lisse, The Netherlands
19.
Hatzidimitriou G , McCann U D , Ricaurte G A (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (β/)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery . J Neurosci19: 5096–5107
20.
Heaton R K , Chelune G J , Talley J L , Kay G G , Curtiss G (1993) Wisconsin Card Sorting Tests Manual revised and expanded. Psychological Assessment Resources Inc., Odessa, FL
21.
Heils A , Teufel A , Petri S , Seemann M , Bengel D , Balling U , Riederer P , Lesch K P (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene . J Neural Transm Gen Sect102: 247–254
22.
Heinz A , Jones D W , Mazzanti C , Goldman D , Ragan P , Hommer D , Linnoila M , Weinberger D R (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity . Biol Psychiatry47: 643–649
23.
Hoehe M R , Wendel B , Grunewald I , Chiaroni P , Levy N , Morris-Rosendahl D , Macher J P , Sander T , Crocq M A (1998) Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders . Am J Med Genet81: 1–3
24.
Hunter A J (1989) Serotonergic involvement in learning and memory . Biochem Soc Trans17: 79–81
25.
Krystal J H , Price L H , Opsahl C , Ricaurte G A , Heninger G R (1992) Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?Am J Drug Alcohol Abuse18: 331–341
26.
Lesch K P , Bengel D , Heils A , Sabol S Z , Greenberg B D , Petri S , Benjamin J , Muller C R , Hamer D H , Murphy D L (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region . Science274: 1527–1531
27.
Liechti M E , Gamma A , Vollenweider F X (2001) Gender differences in the subjective effects of MDMA . Psychopharmacology154: 161–168
28.
Little K Y , McLaughlin D P , Zhang L , Livermore C S , Dalack G W , McFinton P R , Proposto Z S , Hill E , Cassin B J , Watson S J , Cook E H (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsAm J Psychiatry155: 207–213 .
29.
Luteijn F , van der Ploeg F A E (1983) Groninger Intelligentie Test. Swets & Zeitlinger, Lisse, The Netherlands
30.
McCann U D , Ridenour A , Shaham Y , Ricaurte G A (1994) Serotonin neurotoxicity after (β/)3,4-methylenedioxymethamphetamine (MDMA; ‘Ecstasy’): a controlled study in humans . Neuropsychopharmacology10: 129–138
31.
McCann U D , Szabo Z , Scheffel U , Dannals R F , Ricaurte G A (1998) Positron emission tomographic evidence of toxic effect of MDMA (‘Ecstasy’) on brain serotonin neurons in human beings . Lancet352: 1433–1437
32.
McEntee W J , Crook T H (1991) Serotonin, memory, and the aging brain . Psychopharmacology103: 143–149
33.
Meltzer C C , Smith G , DeKosky S T , Pollock B G , Mathis C A , Moore R Y , Kupfer D J , Reynolds C F (1998) Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging . Neuropsychopharmacology18: 407–430
34.
Mendes d O J , Otto P A , Vallada H , Lauriano V , Elkis H , Lafer B , Vasquez L , Gentil V , Passos-Bueno M R , Zatz M (1998) Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia . Am J Med Genet81: 225–227
35.
Meneses A (1999) 5-HT system and cognition . Neurosci Biobehav Rev23: 1111–1125
36.
Milner B (1971) Interhemispheric differences in the localisation of psychological processes in man . Br Med Bull27: 272–277
37.
Morgan M J (1998) Recreational use of ‘ecstasy’ (MDMA) is associated with elevated impulsivity . Neuropsychopharmacology19: 252–264
38.
Morgan M J (1999) Memory deficits associated with recreational use of ‘ecstasy’; (MDMA) . Psychopharmacology141: 30–36
39.
Morgan M J , McFie L , Fleetwood L H , Robinson J A (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?Psychopharmacology159: 295–303
40.
Morley K C , Li K M , Hunt G E , Mallet P E , McGregor I S (2004) Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (‘Ecstasy’) in rats . Neuropharmacology46: 954–965 .
41.
Nelson H E (1991) The Revised National Adult Reading Test Manual. NFER-Nelson, Windsor, UK
42.
O'Hearn E , Battaglia G , De Souza E B , Kuhar M J , Molliver M E (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity . J Neurosci8: 2788–2803
43.
Parrott A C (2000) Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change . Neuropsychobiology42: 17–24
44.
Parrott A C , Lees A , Garnham N J , Jones M , Wesnes K (1998) Cognitive performance in recreational users of MDMA or ecstasy – evidence for memory deficits . J Psychopharmacology12: 79–83
45.
Pope H G Jr , Gruber A J , Hudson J I , Huestis M A , Yurgelun-Todd D (2001) Neuropsychological performance in long-term cannabis users . Arch Gen Psychiatry58: 909–915
46.
Reitan R M (1958) Validity of the Trail Making Test as an indicator of organic brain damage . Perc Mot Skills8: 271–276
47.
Reitan R M (1992) Trail Making Test. Manual for Administration and Scoring. Reitan Neuropsychological Laboratory, Tucson, AZ
48.
Reneman L , Booij J , Schmand B , van den Brink W , Gunning B (2000) Memory disturbances in ‘Ecstasy’ users are correlated with an altered brain serotonin neurotransmission . Psychopharmacology148: 322–324
49.
Reneman L , Booij J , de Bruin K , de Wolff F A , Gunning W B , den Heeten G J , van den Brink W (2001a) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons . Lancet358: 1864–1869
50.
Reneman L , Lavalaye J , Booij J , Schmand B , de Wolff F A , van den Brink W , den Heeten G J , Booij J (2001b) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethaphetamine (MDMA or ‘Ecstasy’) – preliminary findings . Arch Gen Psychiatry58: 901–906
51.
Reneman L , Booij J , Lavalaye J , de Bruin K , Reitsma J B , Gunning W B , den Heeten G J , van den Brink W (2002) Use of amphetamine by recreational users of ecstasy is associated with reduced striatal dopamine transporter densities: a CIT SPECT study . Psychopharmacology159: 335–340
52.
Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris, France
Rodgers J , Buchanan T , Scholey A B , Heffernan T M , Ling J , Parrott A C (2003) Patterns of drug use and the influence of gender on self-reports of memory ability in ecstacy users: a web-based study . J Psychopharmacol17: 389–396
55.
Roiser J P , Cook L J , Cooper J D , Rubinsztein D C , Sahakian B J (2005) Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users . Am J Psychiatry162: 609–612 .
56.
Schifano F , Magni G (1994) MDMA (‘ecstasy’) abuse: psychopathological features and craving for chocolate: a case series . Biol Psychiatry36: 763–767
57.
Schmand B , Lindeboom J , Van Harskamp F (1992). De Nederlandse Leestest voor Volwassenen (The Dutch adult reading test), 1st edn.Swets & Zeitlinger, Lisse, The Netherlands
58.
Schmidt C J , Taylor V L (1987) Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine . Biochem Pharmacol36: 4095–4102
59.
Schmidt C J , Wu L , Lovenberg W (1986) Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue . Eur J Pharmacol124: 175–178
60.
Semple D M , Ebmeier K P , Glabus M F , O'Carroll R E , Johnstone E C (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users . Br J Psychiatry175: 63–69
61.
Spatt J , Glawar B , Mamoli B (1997) A pure amnestic syndrome after MDMA (‘ecstasy’) ingestion . J Neurol Neurosurg Psychiatry62: 418–419
62.
Steele T D , McCann U D , Ricaurte G A (1994) 3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): pharmacology and toxicology in animals and humans . Addiction89: 539–551
63.
Stone D M , Stahl D C , Hanson G R , Gibb J W (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain . Eur J Pharmacol128: 41–48
64.
Stroop J R (1935) Studies of interference in serial verbal reactions . J Exp Psychology18: 643–662 .
65.
Thomasius R , Petersen K , Buchert R , Andresen B , Zapletalova P , Wartberg L , Nebeling B , Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users . Psychopharmacology167: 85–96
66.
Van den Burg W , Saan R J , Deelman B G (1985) 15-Woordentest. Provisional Manual. University Hospital. Groningen, The Netherlands
67.
Verheyden S L , Hadfield J , Calin T , Curran H V (2002) Sub-acute effects of MDMA (β/ 3,4-methylenedioxymethamphetamine, ‘ecstasy’) on mood: evidence of gender differences . Psychopharmacology161: 23–31
68.
Verkes R J , Gijsman H J , Pieters M S , Schoemaker R C , de Visser S , Kuijpers M , Pennings E J , de Bruin D , Van de Wijngaart G , van Gerven J M , Cohen A F (2001) Cognitive performance and serotonergic function in users of ecstasy . Psychopharmacology153: 196–202
69.
Wareing M , Fisk J E , Murphy P N (2000) Working memory deficits in current and previous users of MDMA (‘ecstasy’) . Br J Psychol91: 181–188
70.
Wareing M , Fisk J E , Murphy P , Montgomery C (2004) Verbal working memory deficits in current and previous users of MDMA . Hum Psychopharmacol19: 225–234 .
71.
Wareing M , Fisk J E , Murphy P , Montgomery C (2005) Visuo-spatial working memory deficits in current and former users of MDMA (‘ecstasy’) . Hum Psychopharmacol20: 115–123 .
72.
Wechsler D (1987) Wechsler Memory Scale – Revised. Manual. The Psychological Corporation, San Antonio, TX
73.
Wechsler D (1997) WMS-III/WMD-III. Technical Manual. The Psychological Corporation, San Antonio, TX
74.
Willeit M , Stastny J K , Pirker W (2001) No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism . Biol Psychiatry50: 8–12
75.
Wilson B , Cockburn J , Baddeley A (1985) The Rivermead behavioural memory test. Thames Valley Test Company, Reading, UK
76.
de Win M M , Reneman L , Reitsma J B , den Heeten G J , Booij J , van den Brink W (2004) Mood disorders and serotonin transporter density in ecstasy users – the influence of long-term abstention, dose, and gender . Psychopharmacology173: 376–382
